scholarly article | Q13442814 |
P356 | DOI | 10.1097/TP.0000000000000183 |
P698 | PubMed publication ID | 25243513 |
P50 | author | Pieter Evenepoel | Q96111302 |
Katrien De Vusser | Q114455284 | ||
Maarten Naesens | Q42789801 | ||
Ina Jochmans | Q42879096 | ||
Dirk Kuypers | Q50615819 | ||
Björn Meijers | Q50889585 | ||
Diethard Monbaliu | Q53987520 | ||
Ben Sprangers | Q54301425 | ||
Bert Bammens | Q54301441 | ||
Jacques Pirenne | Q56927509 | ||
Evelyne Lerut | Q90734355 | ||
P2093 | author name string | Kathleen Claes | |
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 427-435 | |
P577 | publication date | 2014-08-01 | |
P1433 | published in | Transplantation | Q15730500 |
P1476 | title | The histology of kidney transplant failure: a long-term follow-up study | |
P478 | volume | 98 |
Q38725625 | Assessing rejection-related disease in kidney transplant biopsies based on archetypal analysis of molecular phenotypes |
Q58803566 | Association between post-transplant uric acid level and renal allograft fibrosis: Analysis using Banff pathologic scores from renal biopsies |
Q37462039 | Biomarkers of Tolerance in Kidney Transplantation: Are We Predicting Tolerance or Response to Immunosuppressive Treatment? |
Q91260277 | CD56+CD57+ infiltrates as the most predominant subset of intragraft natural killer cells in renal transplant biopsies with antibody-mediated rejection |
Q36746647 | Development and validation of a prognostic index for allograft outcome in kidney recipients with transplant glomerulopathy |
Q40513558 | Experience with belatacept rescue therapy in kidney transplant recipients. |
Q89547647 | High numbers of differentiated CD28null CD8+ T cells are associated with a lowered risk for late rejection and graft loss after kidney transplantation |
Q51591178 | Human Pooled Immunoglobulin as Treatment of Active Antibody-Mediated Rejection of Transplanted Kidney. |
Q48206489 | Hyalinosis Lesions in Renal Transplant Biopsies: Time-Dependent Complexity of Interpretation |
Q38542030 | Immunosuppression in the failing and failed transplant kidney: optimizing outcomes |
Q40328463 | Infectious complications as the leading cause of death after kidney transplantation: analysis of more than 10,000 transplants from a single center. |
Q39035802 | Kidney Fibrosis: Origins and Interventions |
Q47786299 | Kidney allograft failure in the steroid-free immunosuppression era: A matched case-control study. |
Q90474075 | Kidney allograft fibrosis: what we learned from latest translational research studies |
Q50037308 | Late Conversion to Belatacept After Kidney Transplantation: Outcome and Prognostic Factors |
Q92589076 | Liposomal Delivery Improves the Efficacy of Prednisolone to Attenuate Renal Inflammation in a Mouse Model of Acute Renal Allograft Rejection |
Q38635428 | Magnetic Resonance Elastography to Assess Fibrosis in Kidney Allografts |
Q90369007 | Magnetic resonance elastography vs. point shear wave ultrasound elastography for the assessment of renal allograft dysfunction |
Q41001229 | Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study. |
Q47876027 | Morphologic patterns and treatment of transplant glomerulopathy: A retrospective analysis |
Q60916304 | Non-invasive Biomarkers of Acute Rejection in Kidney Transplantation: Novel Targets and Strategies |
Q64902782 | Pathological assessment of allograft nephrectomy: An Iranian experience. |
Q89884914 | Pretransplant Donor-Specific Anti-HLA Antibodies and the Risk for Rejection-Related Graft Failure of Kidney Allografts |
Q34483895 | Proteinuria as a Noninvasive Marker for Renal Allograft Histology and Failure: An Observational Cohort Study |
Q36200173 | Quantitative characterization of T-cell repertoire and biomarkers in kidney transplant rejection |
Q41149147 | Recurrent Acute Kidney Injury in Renal Transplant Patients: A Single-Center Study |
Q53103451 | Renal Allograft Histology at 10 Years After Transplantation in the Tacrolimus Era: Evidence of Pervasive Chronic Injury. |
Q38359455 | Renal allograft fibrosis: biology and therapeutic targets |
Q57474736 | Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection |
Q50496236 | Role of Magnetic Resonance Elastography as a Noninvasive Measurement Tool of Fibrosis in a Renal Allograft: A Case Report. |
Q47595221 | T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts. |
Q28554254 | The Spectrum of Renal Allograft Failure |
Q36782862 | The Use of Genomics and Pathway Analysis in Our Understanding and Prediction of Clinical Renal Transplant Injury |
Q50193450 | The causes, significance and consequences of inflammatory fibrosis in kidney transplantation: The Banff i-IFTA lesion |
Q54116671 | The prognostic values of caveolin-1 immunoreactivity in peritubular capillaries in patients with kidney transplantation. |
Q48162490 | The time dependency of renal allograft histology |
Q28069336 | Unraveling the Role of Allo-Antibodies and Transplant Injury |
Q51169417 | Urinary Metabolomics for Noninvasive Detection of Antibody-Mediated Rejection in Children After Kidney Transplantation. |
Q89260318 | Urine biomarkers in renal allograft |
Q36223638 | Variability of the Estimated Glomerular Filtration Rate in the First Year after Kidney Transplantation Is an Independent Risk Factor for Poor Renal Allograft Outcomes: A Retrospective Cohort Study. |
Search more.